作者
J. Fried,Uri Nir,Uri Nir,Claudius Mahr,Uri Nir,Claudius Mahr,Maya Guglin,Maya Guglin,Uri Nir,Uri Nir,Claudius Mahr,Maya Guglin,J. Fried,Maya Guglin,Maya Guglin,Maya Guglin,Uri Nir,J. Fried,Maya Guglin,Uri Nir,J. Fried,Uri Nir,Maya Guglin,Uri Nir,J. Fried,Claudius Mahr,Claudius Mahr,Uri Nir,Claudius Mahr,Uri Nir
摘要
The Impella 5.0 and 5.5 pumps (Abiomed, Danvers, MA) are large-bore transvalvular micro-axial assist devices used in cardiogenic shock (CS) for patients requiring high-capacity flow. Despite their increasing use, real-world data regarding indications, rates of utilization and clinical outcomes with this therapy are limited.